Path toward prognostication and prediction: An evolving matrix

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4599-4601

  Benson III, Al B ^a   Hamilton, Stanley R ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; KI 67 ANTIGEN; LEVAMISOLE; PROTEIN MSH2;

ADJUVANT CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; COLON CANCER; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMORBIDITY; DEFICIENT MISMATCH REPAIR CANCER; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DNA MICROARRAY; EDITORIAL; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LYMPH NODE METASTASIS; MICROSATELLITE INSTABILITY; NEOPLASM; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROGNOSIS; PROGNOSTICATION;

COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 83355166962     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8646     Document Type: Editorial

References (18)

1. Edge SB, Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2010, pp 143-159
2. Washington K, Berlin J, Branton P, et al: Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 133:1539-1551, 2009
3. Sargent D, Marsoni S, Monges G, et al: Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219-3226, 2011
4. Wang Y, Jatkoe T, Zhang Y, et al: Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22:1564-1571, 2004 (Pubitemid 41079793)
5. Bertucci F, Salas S, Eysteries S, et al: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23:1377-1391, 2004 (Pubitemid 38406833)
6. Eschrich S, Yang I, Bloom G, et al: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23:3526-3535, 2005
7. Arango D, Laiho P, Kokko A, et al: Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129:874-884, 2005 (Pubitemid 41242680)
8. Barrier A, Boelle PY, Roser F, et al: Stage II colon cancer prognosis prediction by gene expression profiling. J Clin Oncol 24:4685-4691, 2006 (Pubitemid 46630932)
9. Salazar R, Roepman P, Capella G, et al: Gene expression signature to improve prognosis projection of stage II and III colorectal cancer. J Clin Oncol 29:17-24, 2011
10. Gray RG, Quirke P, Handley K, et al: Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol 29:4611-4618, 2011
11. Kennedy RD, Bylesjo M, Kerr P, et al: Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol 29:4620-4626, 2011
12. O'Connell MJ, Lavery I, Yothers G, et al: Relationship between tumor gene expression and recurrence in four independent studies in patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J Clin Oncol 28:3937-3944, 2010
13. Giacomini CP, Leung SY, Chen X, et al: A gene expression signature of genetic instability in colon cancer. Cancer Res 65:9200-9205, 2005 (Pubitemid 41507985)
14. Vilar E, Gruber SB: Microsatellite instability in colorectal cancer: The stable evidence. Nat Rev Clin Onocl 7:153-162, 2010
15. Figueredo A, Charette ML, Maroun J, et al: Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 22:3395-3407, 2004 (Pubitemid 41103699)
16. Benson AB 3rd, Schrag D, Somerfield MR, et al: American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419, 2004 (Pubitemid 41103700)
17. Engstrom PF, Arnoletti JP, Benson AB 3rd, et al: NCCN Practice Guidelines in Oncology v.1.2011: Colon Cancer. http://www.nccn.org/professionals/ physician-gls/f-guidelines.asp
18. Baggerly KA, Coombes KR: What information should be required to support clinical "omics" publications? Clin Chem 57:688-690, 2011